Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using

Reem Altaf1, Umair Ilyas2, Anmei Ma3,4

  • 1Department of Pharmacy, Iqra University, Islamabad, Pakistan.

Frontiers in Oncology
|April 23, 2024
PubMed

Insights

This study corrects a previous article DOI. The corrected DOI is 10.3389/fonc.2023.1206768.

Area of Science:

  • Correction of scientific literature.
  • Ensuring accuracy in research publications.

Context:

  • A previous article DOI was incorrectly cited.
  • This notice provides the correct article identifier.

Purpose:

  • To rectify an error in the citation of a published article.
  • To ensure proper referencing and discoverability of scientific work.

Summary:

  • The article DOI: 10.3389/fonc.2023.1206768 has been corrected.
  • This correction ensures accurate citation for future references.

Impact:

  • Improves the integrity of scientific records.
  • Facilitates correct access to the research article for readers and researchers.

Related Concept Videos